The Reporting Items for Patent Landscapes statement

The Reporting Items for Patent Landscapes statement

The reporting quality of patent landscapes is inadequate. The Reporting Items for Patent Landscapes (RIPL) checklist can improve reporting quality.

Bibliographic Details
Main Authors:	Smith, J, Arshad, Z, Trippe, A, Collins, G, Brindley, D, Carr, A
Format:	Journal article
Published:	Springer Nature 2018

Similar Items

Evidence of insufficient quality of reporting in patent landscapes in the life sciences
by: Smith, J, et al.
Published: (2017)

Improving transparency and reproducibility of patent landscapes: the Reporting Items for Patent Landscapes (RIPL) statement and other considerations
by: Smith, JA
Published: (2020)

Patent landscape reporting quality and predicting drug approval
by: Smith, J
Published: (2018)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
by: Moher, D, et al.
Published: (2010)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
by: Moher, D, et al.
Published: (2010)

Preferred reporting items of systematic review and meta-analyses: the PRISMA statement
by: Moher, D, et al.
Published: (2011)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
by: Moher, D, et al.
Published: (2009)

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
by: Moher, D, et al.
Published: (2009)

Erratum: Preferred reporting items of systematic review and meta-analyses: The PRISMA statement
by: Moher, D, et al.
Published: (2011)

Reprint-Preferred Reporting items for systematic reviews and meta-analyses: The PRISMA statement
by: Moher, D, et al.
Published: (2009)

Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
by: Moher, D, et al.
Published: (2009)

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (Chinese edition)
by: Moher, D, et al.
Published: (2009)

THE UNIFORM RECOGNITION ITEMS IN THE FINANCIAL STATEMENTS
by: Liana Gadau
Published: (2016-09-01)

Impacts of Newly Acquired Items Within Business Combinations on the Items of the Financial Statements
by: Jana Gláserová
Published: (2016-01-01)

Financial Statement Items, Life Cycle and Bankruptcy
by: Atiyeh Valizadeh Larijani, et al.
Published: (2022-07-01)

DETAILED ANALYSIS ON THE RECOGNITION OF ITEMS IN THE FINANCIAL STATEMENTS
by: GĂDĂU LIANA
Published: (2014-05-01)

CONTROVERSY REGARDING ITEMS EVALUATED IN FINANCIAL STATEMENTS
by: MARILENA-ROXANA ZUCA
Published: (2013-10-01)

CAR-T Cells: A systematic review and mixed methods analysis of the clinical trial landscape
by: Pettitt, D, et al.
Published: (2017)

SPIRIT 2013 statement: defining standard protocol items for clinical trials.
by: Chan, A, et al.
Published: (2013)

The SPIRIT 2013 Statement - Defining Standard Protocol Items for Trials.
by: Agha, R, et al.
Published: (2014)

Preferred reporting items for studies maping onto preference-based outcome measures: the MAPS statement
by: Petrou, S, et al.
Published: (2015)

Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement
by: Petrou, S, et al.
Published: (2015)

Preferred reporting items for studies maping onto preference-based outcome measures: the MAPS statement
by: Petrou, S, et al.
Published: (2016)

Preferred reporting items for studies maping onto preference-based outcome measures: the MAPS statement
by: Petrou, S, et al.
Published: (2015)

Data anonymization patent landscape
by: Mirjana Pejić Bach, et al.
Published: (2017-01-01)

Core outcome Set-STAndardised protocol items: the COS-STAP statement
by: Kirkham, J, et al.
Published: (2019)

Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement
by: Jamie J. Kirkham, et al.
Published: (2019-02-01)

Europe and the Unitary Patent: Progress Towards Reshaping the European Patent Landscape
by: Radcliffe, Bertie
Published: (2012)

The Usefulness of Non-earnings Financial Statements Items as Earnings Predictors
by: Hamid Khaleghi Moghaddam, et al.
Published: (2003-03-01)

Use of Hydrogels for Seawater Desalination Processes: A Patent Landscape Report
by: Ahmed Fatimi
Published: (2023-03-01)

Insufficiency in the reporting of CAR-T manufacturing protocols - a systematic review and mixed-methods analysis
by: Pettitt, D, et al.
Published: (2018)

ANALYSIS OF MEMORANDUM ITEMS IN THE NOTES TO FINANCIAL STATEMENTS BASED ON IT SERVICE PROVIDERS
by: Veronika FENYVES, et al.
Published: (2018-06-01)

OPTIONS FOR THE ASSESSMENT OF ITEMS OF FINANCIAL STATEMENTS AT NATIONAL, EUROPEAN AND INTERNATIONAL LEVEL
by: SILVIA SAMARA
Published: (2010-01-01)

Patent landscape analysis for universities in Asian cities
by: Chan, Y.W., et al.
Published: (2016)